Risk factors for onset of menopausal symptoms. Results from a large cohort study

Maturitas

Volumn 60, Issue 2, 2008, Pages 108-121

  Sabia, Séverine ^a   Fournier, Agnès ^a   Mesrine, Sylvie ^a   Boutron Ruault, Marie Christine ^a   Clavel Chapelon, Françoise ^a  

^a INSERM   (France)

Author keywords

Chronic disease; Diet; Health behaviours; Menopausal symptoms; Reproductive factors

Indexed keywords

ALCOHOL; ORAL CONTRACEPTIVE AGENT; PHYTOESTROGEN;

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATOPY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIETARY INTAKE; EDUCATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; MIGRAINE; OBESITY; PARITY; POSTMENOPAUSE; QUESTIONNAIRE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY ANALYSIS; SMOKING HABIT; THYROID DISEASE; UNDERWEIGHT;

ADULT; ALCOHOL DRINKING; CHRONIC DISEASE; FOOD HABITS; HEALTH SURVEYS; HOT FLASHES; HUMANS; LONGITUDINAL STUDIES; MALE; MENOPAUSE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 45949109156     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.04.004     Document Type: Article

References (53)

1. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005;142(June (12 Pt 1)):1003-13.
2. Gold E.B., Sternfeld B., Kelsey J.L., et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 152 September (5) (2000) 463-473
3. Erlik Y., Meldrum D.R., and Judd H.L. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 59 April (4) (1982) 403-407
4. Freeman E.W., Sammel M.D., Grisso J.A., Battistini M., Garcia-Espagna B., and Hollander L. Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 10 January (1) (2001) 67-76
5. Li C., Samsioe G., Borgfeldt C., Lidfeldt J., Agardh C.D., and Nerbrand C. Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study). Am J Obstet Gynecol 189 December (6) (2003) 1646-1653
6. Schwingl P.J., Hulka B.S., and Harlow S.D. Risk factors for menopausal hot flashes. Obstet Gynecol 84 July (1) (1994) 29-34
7. Wilbur J., Miller A.M., Montgomery A., and Chandler P. Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 5 1 (1998) 43-51
8. Ivarsson T., Spetz A.C., and Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 29 June (2) (1998) 139-146
9. Ford K., Sowers M., Crutchfield M., Wilson A., and Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause 12 May (3) (2005) 308-317
10. Staropoli C.A., Flaws J.A., Bush T.L., and Moulton A.W. Predictors of menopausal hot flashes. J Womens Health 7 November (9) (1998) 1149-1155
11. Gallicchio L., Miller S.R., Visvanathan K., et al. Cigarette smoking, estrogen levels, and hot flashes in midlife women. Maturitas 53 January (2) (2006) 133-143
12. Guthrie J.R., Dennerstein L., Taffe J.R., Lehert P., and Burger H.G. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause 12 July (4) (2005) 460-467
13. Whiteman M.K., Staropoli C.A., Benedict J.C., Borgeest C., and Flaws J.A. Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) 12 June (5) (2003) 459-472
14. Kronenberg F., and Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 137 November (10) (2002) 805-813
15. Riboli E., and Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26 Suppl. 1 (1997) S6-S14
16. van Liere M.J., Lucas F., Clavel F., Slimani N., and Villeminot S. Relative validity and reproducibility of a French dietary history questionnaire. Int J Epidemiol 26 Suppl. 1 (1997) S128-S136
17. Lucas F., Niravong M., Villeminot S., Kaaks R., and Clavel-Chapelon F. Estimation of food portion size using photographs: validity, strengths, weaknesses and recommendations. J Human Nutr Diet 8 (1995) 65-74
18. Sabia S., Fournier A., Mesrine S., Boutron-Ruault M.C., and Clavel-Chapelon F. Risk of onset of menopausal symptoms in periods surrounding menopause. Maturitas 58 4 (2007) 340-347
19. Cornwell T., Cohick W., and Raskin I. Dietary phytoestrogens and health. Phytochemistry 65 April (8) (2004) 995-1016
20. Kesse E., Boutron-Ruault M.C., and Clavel-Chapelon F. Regional dietary habits of French women born between 1925 and 1950. Eur J Nutr 44 August (5) (2005) 285-292
21. Gold E.B., Colvin A., Avis N., et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 96 July (7) (2006) 1226-1235
22. Grossman M.P., and Nakajima S.T. Menstrual cycle bleeding patterns in cigarette smokers. Contraception 73 June (6) (2006) 562-565
23. Siiteri P.K. Adipose tissue as a source of hormones. Am J Clin Nutr 45 January (1 Suppl.) (1987) 277-282
24. Thurston R.C., Sowers M.R., Chang Y., et al. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation. Am J Epidemiol 167 January (1) (2008) 78-85
25. Rico H., Arribas I., Casanova F.J., Duce A.M., Hernandez E.R., and Cortes-Prieto J. Bone mass, bone metabolism, gonadal status and body mass index. Osteoporos Int 13 May (5) (2002) 379-387
26. Freeman E.W., Sammel M.D., Lin H., et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 110 August (2 Pt 1) (2007) 230-240
27. Dennerstein L., Lehert P., Burger H.G., and Guthrie J.R. New findings from non-linear longitudinal modelling of menopausal hormone changes. Hum Reprod Update 13 November (6) (2007) 551-557
28. Bernstein L., Pike M.C., Ross R.K., Judd H.L., Brown J.B., and Henderson B.E. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 74 April (4) (1985) 741-745
29. Nagata C., Kaneda N., Kabuto M., and Shimizu H. Factors associated with serum levels of estradiol and sex hormone-binding globulin among premenopausal Japanese women. Environ Health Perspect 105 September (9) (1997) 994-997
30. Casper R., Dodin S., and Reid R. Study Investigators. The effect of 20 μg ethinyl estradiol/1 mg norethindrone acetate (Minestrin™), a low-dose oral contraceptive, on vaginal bleeding patterns, hot flashes, and quality of life in symptomatic perimenopausal women. Menopause 4 (1997) 139-147
31. Porcile A., Gallardo E., Onetto P., and Schachter D. Very low estrogen desogestrel contraceptive in perimenopausal hormonal replacement. Maturitas 18 (1994) 93-103
32. Shargil A. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study. Int J Fertil 30 (1985) 15-28
33. Mannix L.K., and Calhoun A.H. Menstrual migraine. Curr Treat Options Neurol 6 November (6) (2004) 489-498
34. Silberstein S.D. Migraine. Lancet 363 January (9406) (2004) 381-391
35. Harlow B.L., Wise L.A., Otto M.W., Soares C.N., and Cohen L.S. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 60 January (1) (2003) 29-36
36. Freeman E.W., Sammel M.D., Lin H., Gracia C.R., Kapoor S., and Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 12 May (3) (2005) 258-266
37. Mold J.W., Mathew M.K., Belgore S., and DeHaven M. Prevalence of night sweats in primary care patients: an OKPRN and TAFP-Net collaborative study. J Fam Pract 51 May (5) (2002) 452-456
38. Shahine L.K., and Lathi R.B. Night sweats and elevated follicle-stimulating hormone levels while taking selective serotonin reuptake inhibitors. Obstet Gynecol 108 September (3 Pt 2) (2006) 741-742
39. Stearns V. Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms. Treat Endocrinol 5 2 (2006) 83-87
40. Overlie I., Moen M.H., Holte A., and Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 41 January (1) (2002) 69-77
41. Vasudevan N., Ogawa S., and Pfaff D. Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity. Physiol Rev 82 October (4) (2002) 923-944
42. Schindler A.E. Thyroid function and postmenopause. Gynecol Endocrinol 17 February (1) (2003) 79-85
43. D'Andrea G., Perini F., Terrazzino S., and Nordera G.P. Contributions of biochemistry to the pathogenesis of primary headaches. Neurol Sci 25 October (Suppl. 3) (2004) S89-S92
44. Akdis C.A., and Simons F.E. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 533 March (1-3) (2006) 69-76
45. de Oliveira A.P., Domingos H.V., Cavriani G., et al. Cellular recruitment and cytokine generation in a rat model of allergic lung inflammation are differentially modulated by progesterone and estradiol. Am J Physiol Cell Physiol 293 September (3) (2007) C1120-C1128
46. Dormire S.L., and Reame N.K. Menopausal hot flash frequency changes in response to experimental manipulation of blood glucose. Nurs Res 52 September (5) (2003) 338-343
47. Nagata C., Shimizu H., Takami R., Hayashi M., Takeda N., and Yasuda K. Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women. Climacteric 2 March (1) (1999) 6-12
48. Nagata C., Takatsuka N., Kawakami N., and Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol 153 April (8) (2001) 790-793
49. Touillaud M.S., Thiebaut A.C., Fournier A., Niravong M., Boutron-Ruault M.C., and Clavel-Chapelon F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 99 March (6) (2007) 475-486
50. Hunter M., and O'Dea I. An evaluation of a health education intervention for mid-aged women: five year follow-up of effects upon knowledge, impact of menopause and health. Patient Educ Couns 38 November (3) (1999) 249-255
51. Clavel-Chapelon F., and Dormoy-Mortier N. A validation study on status and age of natural menopause reported in the E3N cohort. Maturitas 29 June (2) (1998) 99-103
52. Obermeyer C.M., Reher D., and Saliba M. Symptoms, menopause status, and country differences: a comparative analysis from DAMES. Menopause 14 July (4) (2007) 788-797
53. Woods N.F., and Mitchell E.S. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 118 December (Suppl. 12B) (2005) 14-24